IP Library › Granted Patent US 7,507,549
Granted Patent B2
US 7,507,549 · App. 10/895,199 · Granted Mar 24, 2009

Method for following the progress of prostate cancer

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,507,549
App. No.
10/895,199
Granted
Mar 24, 2009
Kind
B2
Abstract

This invention provides cDNA encoding a prostate-cancer specific marker, Repro-PC-1.0, Repro-PC-1.0 polypeptides and methods for use in diagnosis and therapy.

Claims (4)

1. A method for use in following the progress of prostate cancer in a subject comprising the steps of:

(a) detecting first and second amounts of mRNA of SEQ ID NO:1 or polypeptide of SEQ ID NO:2 in samples from the subject at a first and a second time; and

(b) comparing the first and second amounts,

whereby an increase between the first and second amounts indicates progression of the prostate cancer and a decrease between the first and second amounts indicates remission of the prostate cancer.

Assignments (2)
CHANGE OF NAME Recorded Jan 8, 2008
From: SIEMENS MEDICAL SOLUTIONS DIAGNOSTICS
To: SIEMENS HEALTHCARE DIAGNOSTICS INC.
Reel/Frame 020333/0976 →
CHANGE OF NAME Recorded Jun 21, 2007
From: DIAGNOSTIC PRODUCTS CORPORATION
To: SIEMENS MEDICAL SOLUTIONS DIAGNOSTICS
Reel/Frame 019510/0695 →